AFYA Stock Recent News

Afya's Q2 2025 results were solid, but the stock faces headwinds from market saturation and regulatory changes in Brazil's medical education sector. Valuation is now more attractive after a 20%+ price drop, but risks from lower pricing power, increased competition, and new quality exams remain significant. The company is shifting capital allocation toward buybacks and dividends, signaling fewer expansion opportunities and a focus on shareholder returns.

Afya Limited (NASDAQ:AFYA ) Q2 2025 Earnings Conference Call August 13, 2025 5:00 PM ET Company Participants Luis Andre Carpintero Blanco - Chief Financial Officer Virgilio Deloy Capobianco Gibbon - Chief Executive Officer Conference Call Participants Flavio Yoshida - BofA Securities, Research Division Lucca Generali Marquezini - Itaú Corretora de Valores S.A., Research Division Marcelo Peev dos Santos - JPMorgan Chase & Co, Research Division Mauricio I Cepeda - Morgan Stanley, Research Division Renan Prata - Citigroup Inc. Exchange Research Samuel Campos Alves - Banco BTG Pactual S.A.

BELO HORIZONTE, Brazil--(BUSINESS WIRE)--Afya Limited (Nasdaq: AFYA; B3: A2FY34) (“Afya” or the “Company”), the leading medical education group and medical practice solutions provider in Brazil, reported today its financial and operating results for the three and six-month period, which ended June 30, 2025 (second quarter 2025). Financial results are expressed in Brazilian Reais and are presented in accordance with International Financial Reporting Standards (IFRS). Second-Quarter 2025 Highligh.

BELO HORIZONTE, Brazil--(BUSINESS WIRE)--Afya Limited (Nasdaq: AFYA; B3: A2FY34) ("Afya" or the "Company"), the leading medical education group and medical practice solutions provider in Brazil, announced today, its Board of Directors has approved a new share repurchase program. Under the share repurchase program, Afya may repurchase up to 4,000,000 of its outstanding Class A common shares, in the open market, based on prevailing market prices, or in privately negotiated transactions, beginning.

Here are three stocks with buy ranks and strong growth characteristics for investors to consider today August 6th:

Morgan Stanley upgraded Afya to Equal Weight from Underweight with a price target of $17.50, down from $19, as part of a broader research note on Brazil Education Services. The new sector regulation will both reshape industry structure and reset economic equilibrium, the analyst tells investors in a research note. Despite long-term medical school risks, the firm sees strong short-term earnings and a narrower valuation gap relative to peers, Morgan Stanley added. 13 Aug

PRIM, AFYA and JBL made it to the Zacks Rank #1 (Strong Buy) growth stocks list on August 4, 2025.

AFYA, ROAD and PAAS made it to the Zacks Rank #1 (Strong Buy) growth stocks list on July 31, 2025.

AFYA, ROAD and PAAS made it to the Zacks Rank #1 (Strong Buy) growth stocks list on July 29, 2025.

Investors looking for stocks in the Schools sector might want to consider either Afya (AFYA) or Grand Canyon Education (LOPE). But which of these two stocks is more attractive to value investors?